Leadiant Biosciences, S.p.A is a Rome-based global holding company, with subsidiaries in the US (Leadiant Biosciences, Inc.) and Europe (Leadiant Biosciences, Ltd, Leadiant Biosciences SASU and Leadiant GmbH). For region or country-specific product information, use the dropdown below.
| Brand name (active ingredient) | Disease Area | Stage of commercialization | Company |
| (Chenodeoxycholic acid) | Cerebrotendinous Xanthomatosis | Under registration with EMA | Leadiant Biosciences Ltd. |
| Natulan (procarbazine) | Hodgkin lymphoma and brain cancers | Registered | Leadiant Biosciences Ltd. |
| elapegademase | adenosine deaminase severe combined immunodeficiency (ADA – SCID) | Phase III | Leadiant Biosciences, Inc. |
| chenodiol | cerebrotendinous xanthomatosis (CTX) | NDA submitted | Leadiant Biosciences, Inc. |
| Matulane® (procarbazine hydrochloride) | oligodendrogliomas, oligoastrocytomas, and astrocytomas | sNDA preparation | Leadiant Biosciences, Inc. |
| Abelcet® (amphotericin B lipid complex injection) | Invasive fungal infections | Marketed | Leadiant Biosciences, Inc. |
| Adagen® (pegademase bovine) | adenosine deaminase severe combined immunodeficiency (ADA – SCID) | Marketed | Leadiant Biosciences, Inc. |
| Carnitor® (levocarnitine) Tablets, Oral Solution, Sugar-Free Oral Solution, and Injection | carnitine deficiency | Marketed | Leadiant Biosciences, Inc. |
| Cystaran® (cysteamine ophthalmic solution) 0.44% | cystinosis | Marketed | Leadiant Biosciences, Inc. |
| DepoCyt® (cytarabine liposome injection) | lymphomatous meningitis | Marketed | Leadiant Biosciences, Inc. |
| Matulane® (procarbazine hydrochloride) Capsules | Hodgkin’s disease | Marketed | Leadiant Biosciences, Inc. |
Marketed products
| Brand name (active ingredient) | Disease Area | Region/Country of approval | Affiliated Company | |
| Chenodeoxycholic acid Leadiant (chenodeoxycholic acid) | Metabolic | Europe | Leadiant Biosciences, Ltd. | |
| Natulan (procarbazine hydrochoride) | Oncology | Europe | Leadiant Biosciences, Ltd. | |
| Abelcet® (amphotericin B lipid complex injection) | Infectious disease | US, Canada | Leadiant Biosciences, Inc. | |
| *Adagen® (pegademase bovine)
RevcoviTM (recombinant adenosine deaminase) |
Immunology | US | Leadiant Biosciences, Inc. | |
| Carnitor® (levocarnitine) Tablets, Oral Solution, Sugar-Free Oral Solution, and Injection | Metabolic disease/Nephrology | US | Leadiant Biosciences, Inc. | |
| Carnitor® (levocarnitine) Tablets, Oral Solution, and Injection | Metabolic disease/Nephrology | Canada | Leadiant Biosciences, Inc. | |
| Cystaran® (cysteamine ophthalmic solution) 0.44% | Metabolic disease / ophthalmology | US | Leadiant Biosciences, Inc. | |
| Matulane® (procarbazine hydrochloride) | Oncology | US, Canada |
|
*Adagen® no longer available from 2019, to be replaced by RevcoviTM
Updated March 2019
Important Note
For patients: if you wish to report an adverse event related to one of our products, please contact your healthcare provider. In addition, you can contact us on safety@leadiantbiosciences.com.
For healthcare professionals: if you wish to report an adverse event related to one of our products, please follow the current regulatory procedure in force in your country or contact us at safety@leadiantbiosciences.com.
For patients or healthcare professionals in the United States and Canada: if you wish to report an adverse event related to one of our products, please contact us at leadiant@tmacmail.com.
